European Archives - Page 9 of 1139 - European Medical Journal

Flu Vaccine Prevented Over 100,000 Hospitalisations Last Winter

Flu vaccination prevented up to 120,000 hospital admissions in England during the 2024/25 season, despite concerning declines in uptake among some vulnerable groups.

Autism in Toddlers: No Early Sex Differences at First Diagnosis

Major study finds no early clinical differences between autistic boys and girls at the time of first diagnosis.

ESPID 2025: Spain’s Infant Antibody Programme Outperforms UK Maternal Vaccine

A comparison of national RSV prevention strategies has shown that monoclonal antibody immunisation in Spain was vastly more effective than maternal vaccination in the UK.

Tezepelumab Achieves Clinical Remission in Severe Asthma

Interestingly, the study also revealed a disconnect between clinical and biological remission.

Addressing the Burden of Atopic Dermatitis on the Head and Neck

Explore the impact of atopic dermatitis on visible areas like the head and neck, affecting approximately 70% of patients with moderate to…

EMJ Allergy & Immunology 10 [Supplement 2] 2025

Hereditary angioedema (HAE) attacks can be debilitating and potentially life-threatening, particularly when they affect the abdomen or…

Berotralstat for HAE Prophylaxis

Hereditary angioedema (HAE) attacks can be debilitating and potentially life-threatening, particularly when they affect the…

King’s Fund sheds light on access to medicine in UK

The King’s Fund in the UK has released an updated explainer on the availability of new medicines in the UK’s NHS.

Pemafibrate Reduces Liver Fat and Heart Disease Risk

A study has revealed that pemafibrate is more effective than omega-3 fatty acid ethyl in reducing fatty liver index.

Beta-Blocker Discontinuation After Myocardial Infarction Linked to Increased Risks

Beta-blocker interruption after heart attack raises blood pressure and heart rate, increasing risks especially in hypertensive patients.